ISSN 2518-0381 Volume 1 Number 1 Nobember 2016 The ...

10
The Cambodian Journal of Nephrology Volume 1 Number 1 Nobember 2016 Meeting Issue The first annual meeting of Cambodian Association of Nephrology 2016 Lim Vadhana, Congress President C A M B O D I A N A S S O C I A T I O N O F N E P H R O L O G Y ISSN 2518-0381

Transcript of ISSN 2518-0381 Volume 1 Number 1 Nobember 2016 The ...

The Cambodian Journal of Nephrology

Volume 1 Number 1 Nobember 2016

Meeting IssueThe first annual meeting of Cambodian Association of Nephrology 2016Lim Vadhana, Congress President

CA

MBO

DIAN ASSOCIATION OF NEPHROLO

GY

ISSN 2518-0381

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016 1

The Cambodian Journal of Nephrology

CONTENTS

Welcome Letter

Welcome Message to Attendees of β€œThe first annual conference of Cambodian Association of Nephrology 2016”Lim Vadhana

The first annual conference of Cambodian Association of Nephrology 2016 Preliminary Program

Abstracts

Management of Chronic kidney disease in Cambodia

Lim Sochun

Dialysis Patients in CambodiaSovann Kanitha

Easy and Precise Detection of Glomerular and Non-Glomerular Hematuria by the Automated Urinary Flowcytometer : History of Development of the World-Wide Available CriteriaToru Hyodo

Importance of engineering in dialysis therapyKenichi Kokubo

Dialysis column

Significance of the inter-dialytic weight gain: A 1-kg increase corresponds to the consumption of 8 g of salt.Toru Hyodo

01

02

03

10

Where a manuscript is posted in the Journal in multiple languages and where there is any discrepancy between the versions in different languages, the Eng-lish language version will prevail over the others.

αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αž”αžΆαž“αž…αŸ‡αž•αžŸαžΆαž™αž€αž“αž„αž‘αžŸαžŸαž“αžΆαžœαžŠαžαŸαž™αž„αžαžšαžαžœαž”αžΆαž“αžŸαžšαŸαžŸαžšαž‡αžΆαž—αžΆαžŸαžΆαŸαž•αžŸαž„αŸ— αŸαž αžαžŠαŸαž…αž“αŸ‡

αž€αž“αž„αž€αžšαžŽαž˜αžΆαž“αž€αžΆαžšαžšαžŸαž–αž…αžšαžŸαž–αž›αŸαž‘αŸ…αŸαž›αž–αžΆαž€αž™αž¬αž—αžΆαžŸαžΆαžŽαžΆαž˜αž™ αŸαž™αž„αžŸαž˜αž•αžαž›αž’αžΆαž‘αž—αžΆαž–αŸαž‘αŸ…αžŠαž›

αž’αžαžαž“αž™αŸƒαž“αžšαž”αŸαž™αžΆαž‚αŸ‚αžŠαž›αž‡αžΆαž—αžΆαžŸαžΆαž’αž„αŸαž‚αž›αžŸ αŸ”

Welcome Letter

Remark by Dr. Lim Vadhana

President of the Cambodian Association of Nephrology,

At the 1st Annual Conference of the Cambodian Association of Nephrology,

26 November 2016, Phnom Penh, Cambodia

Good Morning - His Excellency Prof. KHOUN Pichit, advisor to Ministry of Health,- Professor Toru Hyodo, Secretary General of the NGO Ubiquitous Blood Purifi cation International, Yokohama, Japan, - Professors, Doctors,- Ladies and Gentlemen,Let me fi rst extend my very warm welcome to all of you present here to attend the First Annual Conference of the Cambodian Association of Nephrology in Phnom Penh, Cambodia. Today I am very pleased to be a Chair of this conference. In this meaningful occasion, I would like to highlight the history of the Cambodian Association of Nephrology before we start this conference. Cambodian Association of Nephrology was established 2016 which signed by Ministry of Interior. This Association was created on the purpose of promoting the health of kidney, connecting the network between the doctors, professors, experts who are specialist on Nephrology and Dialysis both national and international, and creating the forum to discuss as well as to share their professional experiences in the effective management on the treatment Kidney Diseases.Taking this opportunity, on behalf of Cambodian Association of Nephrology, I also would like to thank Professor Toru Hyodo who always helps and supports Cambodian Association of Nephrology and Roche Company for sponsoring this Association and the Conference.I call for the conference to be start.Thanks.

αžŸαž˜αŸαž‚αžΆαžšαž–αž―αž€αž§αžαžαž˜αžŸαžΆαžšαžŸαžΆαž αž…αžΆαžšαž™ αžƒαž“ αž–αž‡αž αž‘αžšαž”αž€αžŸαžΆαžšαž€αžŸαž„αžŸαžαžΆαž—αž”αžΆαž› αŸαž›αžΆαž€αžŸαžΆαžšαžŸαžΆαž αž…αžΆαžšαž™ Toru Hyodo

αž’αž‚αž‚αŸαž›αžαžΆαž’αž€αžΆαžšαŸƒαž“ NGO Ubiquitous Blood Purification Internationalαž‘αžšαž€αž„Yokohama αžšαž”αŸαž‘αžŸαž‡αž”αž“

αŸαž›αžΆαž€αžŸαžΆαžšαžŸαžαž…αžΆαžšαž™ αŸαžœαž‡αž‡αž”αžŽαžŒ ត αŸαž›αžΆαž€ αŸαž›αžΆαž€αžšαžŸ αž’αž“αž€αž“αžΆαž„ αž€αž‰αžΆαž‰ αŸ‚αžŠαž›αž˜αžΆαž“αžœαžαžαž˜αžΆαž“αŸαž“αŸ…αž€αž“αž„αžŸαž“αž“αžŸαž‘αžšαž”αž…αžΆαž†αžΆαž“ αŸƒαž“αžŸαž˜αžΆαž‚αž˜

αžšαž‚αŸαž–αž‘αž™αžαžšαž˜αž„αŸαž“αžΆαž˜αž€αž˜αž–αž‡αžΆαŸαž›αž€αž‘αŸ‘ αŸαž“αŸ…αž‘αžšαž€αž„αž—αž“αŸαž–αž‰ αžšαž”αŸαž‘αžŸαž€αž˜αž–αž‡αžΆαŸ” αŸƒαžαž„αŸαž“αŸ‡ αžαž˜αžΆαž“αž€αžαžαž™αžŸαŸ‚αžŠαž›αž”αžΆαž“αžšαž”αž’αžΆαž“αŸƒαž“αžŸαž“αž“αžŸαž‘αŸαž“αŸ‡αŸ”

αŸαž“αŸ…αž€αž“αž„αž±αž€αžΆαžŸαžŠαžœαŸαžŸαžŸαžœαžŸαžΆαž›αŸαž“αŸ‡ αžαž˜αžΆαž“αž€αžαžαž™αžŸαž€αž“αž„αž€αžΆαžšαŸαžšαŸ€αž”αžšαžΆαž”αž’αž–αžšαž”αžœαžαžαŸƒαž“αžŸαž˜αžΆαž‚αž˜αžšαž‚αŸαž–αž‘αž™αžαžšαž˜αž„αŸαž“αžΆαž˜αž€αž˜αž–αž‡αžΆαŸ” αžŸαž˜αžΆαž‚αž˜αŸαž“αŸ‡

αžšαžαžœαž”αžΆαž“αž”αŸαž„αž€αžαŸαž‘αž„αž€αž“αž„αž†αžΆαž“ ្០៑៦ αŸαžŠαžΆαž™αž˜αžΆαž“αž€αžΆαžšαž…αŸ‡αž αžαžαŸαž›αžαžΆαŸαžŠαžΆαž™αžšαž€αžŸαž„αž˜αž αžΆαŸƒαž•αž‘αŸ” αžŸαž˜αžΆαž‚αž˜αŸαž“αŸ‡ αž”αŸαž„αž€αžαŸαž‘αž„αž€αž“αž„αŸαž‚αžΆαž›αž”αžŽαž„

αž–αžšαž„αž„αžŸαžαž—αžΆαž–αžαžšαž˜αž„αŸαž“αžΆαž˜ αž€αžΆαžšαž”αŸαž„αž€αžαž‘αž“αžΆαž€αž‘αž“αž„αžšαžœαžΆαž„αžšαž‚αŸαž–αž‘αž™ សអរសអត αž…αžΆαžšαž™ αž’αž“αž€αž‡αž“αžΆαž‰αŸαž“αŸ…αž€αž“αž„αŸ‚αž•αž“αž€αžαžšαž˜αž„αŸαž“αžΆαž˜ αž“αž„αž›αžΆαž„αžˆαžΆαž˜

αž‘αžΆαž„αžαžΆαž“ αž€αž‡αžΆαž αž“αž„αž’αž“αžαžšαž‡αžΆαž αž€αžŠαž…αž‡αžΆαž€αžΆαžšαž•αžΆαž› αžŸαž”αžαžšαž‚αžΆαž“ αž“αžœαž”αž‘αž–αŸαžŸαžΆαž’αž“αž‡αž“αžΆαž‰αŸαžŠαž˜αž”αžšαž‚αž”αžšαž‚αž„αž€αžΆαžšαž–αž™αžΆαž”αžΆαž›αžšαž”αž€αž”αŸαžŠαžΆαž™αžšαž”αžŸαž‘αž’αž—αžΆαž–αŸαž›

αž‡αž˜αž„αžαžšαž˜αž„αŸαž“αžΆαž˜αŸ”

αŸαž†αž›αŸ€αžαž€αž“αž„αž±αž€αžΆαžŸαŸαž“αŸ‡αž•αž„αŸ‚αžŠαžš αžαžΆαž„αž“αžΆαž˜αž²αž™αžŸαž˜αžΆαž‚αž˜αžšαž‚αŸαž–αž‘αž™αžαžšαž˜αž„αŸαž“αžΆαž˜αž€αž˜αž–αž‡αžΆ αžαžŸαž˜αŸ‚αžαž›αž„αž’αžŽαžšαž‚αžŽαž™αžΆαž„αžšαž‡αžΆαž›αŸαžšαž‡αŸ… αž…αŸαž–αžΆαŸ‡αž€αžΆαžšαž‡

αž™αž§αž”αžαžαž˜αž—αž‚αžΆαžšαž‘αžšαž”αžŸαŸαž›αžΆαž€αžŸαžΆαžšαžŸαžΆαž αž…αžΆαžšαž™ Toru Hyodo αž€αžŠαž…αž‡αžΆαž€αžΆαžšαž§αž”αžαžαž˜αž—αžšαž”αžŸαžšαž€αž˜αž αž“Roche αŸ‚αžŠαž›αž”αžΆαž“αž‡αž™αž‚αžΆαžšαž‘αžŠαž›αžŸαž˜αžΆαž‚αž˜

αž“αž„αžŸαž“αž“αžŸαž‘αŸαž“αŸ‡αŸ”

αžαžŸαž˜αžšαž”αž€αžΆαžŸαŸαž”αž€αžŸαž“αž“αžŸαž‘αŸαž“αŸ‡αž‡αžΆαž•αž›αžœαž€αžΆαžšαŸ”

αžŸαž˜αž’αžšαž‚αžŽ

The Cambodian Journal of Nephrology

CONTENTS

Welcome Letter

Welcome Message to Attendees of β€œThe first annual conference of Cambodian Association of Nephrology 2016”Lim Vadhana

The first annual conference of Cambodian Association of Nephrology 2016 Preliminary Program

Abstracts

Management of Chronic kidney disease in Cambodia

Lim Sochun

Dialysis Patients in CambodiaSovann Kanitha

Easy and Precise Detection of Glomerular and Non-Glomerular Hematuria by the Automated Urinary Flowcytometer : History of Development of the World-Wide Available CriteriaToru Hyodo

Importance of engineering in dialysis therapyKenichi Kokubo

Dialysis column

Significance of the inter-dialytic weight gain: A 1-kg increase corresponds to the consumption of 8 g of salt.Toru Hyodo

01

02

03

10

Where a manuscript is posted in the Journal in multiple languages and where there is any discrepancy between the versions in different languages, the Eng-lish language version will prevail over the others.

CA

MBO

DIAN ASSOCIATION OF NEPHROLO

GY

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016 1

Welcome Letter

Remark by Dr. Lim Vadhana

President of the Cambodian Association of Nephrology,

At the 1st Annual Conference of the Cambodian Association of Nephrology,

26 November 2016, Phnom Penh, Cambodia

Good Morning - His Excellency Prof. KHOUN Pichit, advisor to Ministry of Health,- Professor Toru HyodoYokohama, Japan, - Professors, Doctors,- Ladies and Gentlemen,

the First Annual Conference of the Cambodian Association of Nephrologybe a Chair of this conference.

Cambodian Association of Nephrology before we start this conference. Cambodian Association of Nephrology was established

health of kidney, connecting the network between the doctors, professors, experts who are specialist on Nephrology and Dialysis both national and international, and creating the forum to discuss as well as to share their professional experiences in the effective management on the treatment Kidney Diseases.Taking this opportunity, on behalf of Cambodian Association of NephrologyProfessor Toru Hyodo who always helps and supports Cambodian Association of Nephrology and Roche

Thanks.

Toru Hyodo

CA

CCM

AAB

MMOB

DOO

IDDAII NAA

ASAASS OS CO ICC AII TAA ITT OI NOO OFOO NENN

PEEHPP

RHH

ORRL

OOOLL

GO

YGG

CA

MBO

DIAN ASSOCIATION OF NEPHROLO

GY

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 20162 3

The first annual conference ofCambodian Association of Nephrology

2016 Preliminary Program

9:00-9:30 Registration & Welcome

9:30-9:40 Opening Speech by Dr.Lim Vadhana, Chairman

9:40-10:10 Management of CKD in Cambodia Presented by : Lim Sochun, M.D.

10:10-10:40 Easy and Precise Detection of Glomerular and Non-Glomerular Hematuria by the Automated Urinary Flowcytometer : History of Development of the World-Wide Available Criteria

Presented by : Toru Hyodo, M.D. and Ph.D. 10:40-11:10 Dialysis Patients in Cambodia Presented by : Sovann Kanitha, M.D. 11:10-11:40 Importance of engineering in Dialysis Therapy Presented by : Kenichi Kokubo, Ph.D., Associate Professor

11:40-12:00 Recormon provides Better Hb Correction and Safety Profi le for all CKD Patients

Presented by : Ph. Sean Mengorn

12:00-12:30 Question & Answer

12:30-12:40 Conclusion and Closing Ceremony by Dr.Lim Vadhana

12:40-14:00 Lunch at Restaurant, Sokha Phnom Penh Hotel

Date : November 26, 2016

Venu : ISokha Phnom Penh HotelSen Sok, Phnom Penh, Cambodia

Management of Chronic kidney disease in Cambodia

LimSochun, M.D., internist and nephrologist

1) Calmette hospital, Cambodia (Medicine A and CHEA Sim Hemodialysis center) 2) Lecturer of Nephrology, University of Health and Science, Cambodia3) General secretary of Cambodian Association of Nephrology

The chronic kidney disease (CKD) is caused by many diseases such as diabetes, hypertension, nephropathy and other diseases. Its prevalence in adult population varies from one country to another (10 to 20%). But this prevalence is still unknown in Cambodia.

There are 3 steps to manage CKD patients:1-For normal kidney function, Education and prevention of chronic kidney disease play a very important role.2- For CKD risk, we need to arrest the progression and to prevent the complications.3-For the end stage of CKD, the essential is to prevent the complications and to discuss the renal replacement therapy with the patients (hemodialysis, peritoneal dialysis and transplan-tation).

The goal of CKD management is:-To slow down or to stop the progression of chronic renal failure.-To maintain the optimal nutritional status.-To prevent the complications.

To reach this goal, it is important to use nephro-protective drugs and the medicine to ensure optimal blood pressure, adequate glycaemia, anemia and other complications of chronic kidney failure.

In my presentation it is useful to know the situation and the conditions of transferring patients to neph-rologists or emergency hemodialysis in equipped hospitals in Cambodia.

So far, there are nine public and private hemo-dialysis centers in Cambodia. These centers are located only in the capital and major provinces (Phnom Penh, Battambang and Siem Reap).

Abstracts

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 20164 5

Dialysis Patients in Cambodia

Sovann Kanitha, M.D., Nephrologist

1) Ward A of General Medicine and OPD service, Calmette Hospital, Cambodia2) Chea Sim Dialysis Center, Cambodia3) Lecturer of Nephrology, University of Health and Science, Cambodia

The kidneys are powerful chemical factories that perform many tasks such as removing waste products from the body, removing drugs from the body, produce active form of vitamin D, regulating the body’s fl uid, releasing hormone and also stimulating the production of red blood cells. Some people may failed or damaged their kidneys, which cannot carry out the function properly. This caused them an imbalance homeostasis. By this reason, they may need dialysis. Dialysis is the artifi cial process of cleaning waste (diffusion) and unwanted water (Ultrafi ltration) from the blood when the kidney can no longer do the job. We could not live if waste products were not removed from our kidney. People whose kidneys either do not work correctly or not at all experience an increase of waste in their blood. Without dialysis the amount of waste products in the blood would build up and eventually reach levels that would cause coma and death. There are two essential type of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis is a technic of fi ltering waste products and unnecessary water from the blood by circulating the blood outside the body of the patient, where it fl ows through a machine that has special fi lter and goes back into the patient after fi ltering. This procedure takes around 3 to 4 hours per session. Peritoneal Dialysis is another fi ltering process where the patient have to place a soft plastic tube (Catheter) in their belly by surgery then a sterile cleansing fl uid is put into the belly through this

catheter. The fl uid will leave the body through the catheter after the process is done.The dialyzer was fi rst invented by a young Dutch Physician, Dr. Willem Kolff in 1943. At the time of its creation, Kolff’s goal was to help kidneys recover. By the way, his invention becomes one of the foremost life-saving developments in the history of modern medicine. This very helpful technic fi nally came to Cambodia in 1997 where it starts with 4 dialysis machines at Chea Sim Dialysis Center. At that time, Samdach Chea Sim was the one who constructed this center and donated the machines. It is a part of Calmette Hospital, one of the biggest hospital in Cambodia. There were approximately 10 patients who undergo the hemodialysis process there. In 2010, the center was fi rst renovation and was upgraded to 12 machines. The machines was last updated within 2011, from 12 to 26 machines. The center was divided into 2 rooms, where they placed 12 machines in the fi rst room and others 14 machines in another room. The expansion of the center was because of the increasing amount of patients, when there were 3 sessions per day because they did not have enough machines. In 2015, there were 191 patients from every part of the country, 93 patients were female and another 98 patients were male, which most of them had CKD (Chronic Kidney Disease). In total, 11995 sessions of hemodialysis were served in 2015. Nowadays, there are only 2 sessions per day including a duty Nephrologist at night time for emergency case.

Abstracts

There are so many milestones in this small beautiful country on collecting all the kidneys patients and giving them the right treatment. First of all, at Chea Sim Dialysis Center, where there are the most nephrologists of the whole country and still merely has 7 nephrologists with 13 dialysis nurses nowadays. This is one of kidney health care problem that should be solved, when there are approximately 15 million people in the whole country and there are less than 10 nephrologists. Secondly, most of Cambodian patients who undergo the hemodialysis have diffi culty of traveling from their provinces to the city where they have to spend their accommodation fees and also hospital fees. Each patient might have to come twice per week, depending on theirs kidneys condition. Most patients failed to do the hemodialysis punctually, the reason is they have nothing left for their health budget. There is no sponsor for each session at the hospital. In 2013, it was the start of β€œPeritoneal Dialysis” in Cambodia, however it was a pilot project which was sponsored by the International Society of Nephrology (ISN). It was done at Calmette Hospital. The project ended in 2015, which had 3 cases of Acute Kidney Disease (AKD). The result was very satisfy without any complications. These days, we are waiting for the chronic project.

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 20166 7

AbstractsAbstracts

αž€αžΆαžšαž€αžŽαž Glomerular αž“αž„ Non-Glomerular Hematuria αŸ‚αžŠαž›αž„αžΆαž™αžšαžŸαž›αž“αž„αž…αž”αžΆαžŸαž›αžΆαžŸαŸαžŠαžΆαž™ Automated Urinary Flowcytometer: αžšαž”αžœαžαžαžŸαžΆαžšαžŸαžαŸƒαž“αž€αžΆαžšαž’αž—αžœαžŒαžαž›αž€αžαžαžŽαžŒ αžœαž“αž…αž†αž™αžŠαž‘αž›αž‘αž›αžΆαž™αž‡αžΆαž›αž€αžαžŽαŸˆαžŸαžΆαž€αž›

αŸαž›αžΆαž€αžŸαžΆαžšαžŸαžΆαž αž…αžΆαžšαž™αž”αžŽαžŒ ត Toru Hyodo, M.D. and Ph.D

1) αž‚αž›αž“αž€αŸαž’αž™αž™αž“(Eijin) αž“αž„ αž˜αž“αž‘αžšαŸαž–αž‘αž™αž“αž„αž˜αž‡αžˆαž˜αžŽαžŒ αž›αž›αžΆαž„αžˆαžΆαž˜αžƒαžšαžΆαžαžΆ (Kurata), αž‘αžšαž€αž„αž αžšαžΆαžŸαžŸαž€αžΆ (Hiratsuka) αžšαž”αŸαž‘αžŸαž‡αž”αž“

2) αžŸαžΆαž€αž›αžœαž‘αž™αžΆαž›αž™ Kitasato αŸ‚αž•αž“αž€αžαžšαž˜αž„αŸαž“αžΆαž˜ Sagamihara, αžšαž”αŸαž‘αžŸαž‡αž”αž“

3) αž’αž„αž‚αž€αžΆαžš NGO Ubiquitous Blood Purification International αž‘αžšαž€αž„αž™αž€αž αžΆαž˜αžΆ αžšαž”αŸαž‘αžŸαž‡αž”αž“

αŸαž“αŸ…αž€αž“αž„αž†αžΆαž“ ៑៩៧៩ αŸαž›αžΆαž€ Birch αž“αž„ Fairly [1]

αž”αžΆαž“αžšαžΆαž™αž€αžΆαžšαžŽαžαžΆ αŸαž€αžΆαžŸαž€αžΆαžˆαžΆαž˜αžšαž€αž αž˜αŸ‚αžŠαž›αž˜αžΆαž“αŸαž“αŸ…αž€αž“αž„αž‘αž€αŸαž“αžΆαž˜

(RBC) αž’αžΆαž…αž”αŸ‚αž˜αž›αž„αŸαž‘αŸ…αž‡αžΆ glomerular αž“αž„ non-glomerular

αŸαžšαž€αžΆαž˜αžŠαžŽαžΆαž€αž€αžΆαž› phase contrast microscope αŸ”

αž€αžΆαžšαžŸαž€αžŸαžΆαŸαžšαž€αžΆαž™αŸ—αž˜αž€αž€αž”αžΆαž“αž‘αž‘αž›αž›αž‘αž’αž•αž›αžŠαž…αŸ‚αžŠαž›αž’αž“αž€αž‘αžΆαž„αž–αžšαž”αžΆαž“αžšαžΆαž™

αž€αžΆαžšαž•αž„αŸ‚αžŠαžš αŸαž αž™αŸαž‚αž€αž”αžΆαž“αžŸαžšαŸαžŸαžšαžœαžΆαž…αž›αŸαž‘αŸ…αž€αž“αž„αŸαžŸαŸ€αžœαŸαž—αŸ…αžŠαž›αž”αŸαžˆαžΆαž˜ αŸ‡

αŸ‚αžŠαž›αž˜αžΆαž“αŸαžˆαžΆαž˜ αŸ‡αžαžΆ Campbell’s Urology and Smith’s General

UrologyαŸ” αž€αž”αŸ‚αž“αž αž€αžΆαžšαŸ‚αž”αž„αŸ‚αž…αž€ RBC αŸ‚αžŠαž›αž˜αžΆαž“αŸαž“αŸ…αž€αž“αž„αž‘αž€αŸαž“αžΆαž˜

αŸαžŠαžΆαž™αŸαžšαž”αžšαž”αžΆαžŸ light microscope αŸαž“αžΆαŸ‡ αž‚αž’αžΆαž…αŸ‚αžšαž”αžšαž”αž›αŸαž‘αŸ…αžαžΆαž˜

Subjective visual assessment αŸαžŠαžΆαž™αŸ‚αž—αž“αž€αžšαž”αžŸαž˜αž“αžŸαžŸ,

αžαžšαž˜αžœαŸαž’αžΆαž™αž˜αžΆαž“αž‡αž“αžΆαž‰αž…αž”αžΆαžŸαž›αžΆαžŸ, αž˜αž™αžΆαž„αžœαž‰αŸαž‘αŸ€αž

αžœαžΆαž’αžΆαž…αž˜αžΆαž“αž—αžΆαž–αžαžŸαž‚αžΆαž“ αŸαž‘αŸ…αžαžΆαž˜αž’αž“αž€αž–αŸαžŸαžΆαž’αž“αž“αž˜αž™αŸ— αž€αžŠαž…αž‡αžΆ

αž‘αžΆαž˜αž‘αžΆαžšαŸαž–αž›αŸαžœαž›αžΆαŸαžšαž…αž“αž•αž„αŸ‚αžŠαžš αŸ” αŸαžŠαžΆαž™αžŸαžΆαžšαŸαž αžαŸαž“αŸ‡αŸαž αž™ αŸαž‘αžΆαŸ‡

αž”αžšαž™αŸˆαŸαž–αž› αŸ’αŸ αž†αžΆαž“ αž€αž“αž›αž„αž•αžαŸαž‘αŸ…αŸαžšαž€αžΆαž™αž–αž€αžΆαžšαžšαžΆαž™αž€αžΆαžšαžŽαžŠαž”αž„αž€αŸαžŠαžΆαž™

αž€αŸαž‚αž˜αž“αž‘αžΆαž“αŸαžƒαž‰αž˜αžΆαž“αž€αžΆαžšαŸ‚αžŽαž“αžΆ αž¬αž’αž“αžœαžαžαž‡αžΆαž•αž›αžœαž€αžΆαžšαŸαž“αŸ…αž€αž“αž„αŸ‚αž•αž“αž€αŸαžœαž‡αž‡αžŸαžΆ

αžšαžŸαžαŸαž“αŸ…αŸαž‘αž™αŸαž‘ αŸ” αž€αž‘αž„αž†αžΆαž“ ៑៩៨០ αž“αž„ ៑៩៩០ αž‚αž‡αžΆαž†αžΆαž“ αŸ‚αžŠαž›αžœαž’αžŸαžΆ

αžšαžŸαžαž€αž“αž„αž€αžΆαžšαŸ‚αžŸαžœαž„αžšαž€αž“αžœ glomerular αž“αž„ non-glomerular hematuria

αž˜αžΆαž“αž€αžΆαžšαŸαž‡αžΏαž“αŸαž›αžΏαž“ αŸαž αž™αž€αžΆαžšαžšαž”αž€αžαŸ‚αž”αž”αž’αž“αžαžšαž‡αžΆαžαž€αžšαžαžœαž”αžΆαž“αž’αž“αžœαžαžαž•αž„

αŸ‚αžŠαžšαŸ”

αŸαž“αŸ…αž€αž“αž„αž†αžΆαž“ ៑៩៩αŸ₯ automated urinary flow cytometer (UFCM)

αžšαžαžœαž”αžΆαž“αž’αž—αžœαžŒαžαž“αžαž˜ utilize flow cytometry αž“αž„

αžœαž’αžŸαžΆαžšαžŸαžαž€αž“αž„αž€αžΆαžšαŸ‚αžŸαžœαž€αžšαž€ impedance method urinary particles

αŸαžŠαžΆαž™αž˜αž‡αžαž˜αžŽαžŒ αž›αžαžšαž˜αž„αŸαž“αžΆαž˜αŸƒαž“αžŸαžΆαž€αž›αžœαž‘αž™αžΆαž›αž™αžƒαžαžΆαžŸαžΆαž(Kitasato)

αž“αž„ αžšαž€αž˜ Sysmex αŸƒαž“αžšαž”αŸαž‘αžŸαž‡αž”αž“ αŸ” αž’αž“αž€αŸαžŠαžšαžαžŠαžŸαžαžΆαž“αž€αž“αž„αž€αžΆαžš

αžšαžŸαžΆαžœαžšαž‡αžΆαžœαŸαž“αŸ‡αž‚αŸαž›αžΆαž€αžŸαžΆαžšαžŸαžΆαž αž…αžΆαžšαž™αž”αžŽαžŒ ត ថរ αž αž™αžŠ Toru Hyodo,

MD αž“αž„ PhD αŸ” αžœαž’αžŸαžΆαžšαžŸαžαŸαž“αžΆαŸ‡αžšαžαžœαž”αžΆαž“αŸαž…αž‰αž•αžŸαžΆαž™αŸαž“αŸ…αž€αž“αž„

Nephron αž€αž“αž„αž†αžΆαž“ ៑៩៩៩ [2] αž…αŸ‚αžŽαž€αž―αž€αžΆαžšαŸαž•αž‘αŸ€αž„αž•αžΆαž‘ αžŸαž—αžΆαž–αž…αž”αžΆαžŸαž›αžΆ

αžŸαžšαžαžœαž”αžΆαž“αŸαž’αžœαŸαž‘αž™αŸαžŠαžΆαž™αžšαž€αž˜αžšαžŸαžΆαžœαžšαž‡αžΆαžœαŸƒαž“αžšαž”αŸαž‘αžŸαž’αžšαž” [3] αŸαž αž™

UFCM αž€αžšαžαžœαž”αžΆαž“αŸαž‚αž‘αž‘αž›αžŸαžΆαž‚ αž›αžαžΆαž‚αž‡αžΆαž˜αŸαž’αž™αžΆαž”αžΆαž™αž€αž“αž„αž€αžΆαžšαŸαž’αžœαŸαžšαžΆαž‚αžœαž“αž…αž†

αž™αŸαž•αžŸαž„αŸ—αž‚αžΆαž“ αŸƒαž“ hematuria αžŠαž˜αžΆαž“αžŸαžΆαžšαžšαž”αŸαž™αžΆαž‡αž“αž•αž„αŸ‚αžŠαžš αŸ” αŸαž‚αž”αžΆαž“

αž™αž€αžœαžΆαž˜αž€αŸαžšαž”αžšαž”αžΆαžŸαž€αž“αž„αž€αžΆαžšαŸαž’αžœαŸαžαžŸαžαž–αž“αžαž™αŸαžŠαž˜αž”αŸ‚αž”αž„αŸ‚αž…αž€αž—αžΆαž–αžαžŸαž‚αžΆαž“ αžšαžœαžΆαž„

glomerular αž“αž„ non-glomerular hematuria αŸαžŠαžΆαž™αžŸαžΆαžšαŸ‚αžαžœαžΆαž’αžΆ

αž…αŸαž’αžΆαž™αŸαž™αž„αŸαž’αžœαž€αžΆαžšαž–αž“αžαž™αŸαž˜αž›αž‚αžšαž‡αžΆαŸαžšαž…αž“αž€αž“αž„αžšαž™αŸˆαŸαž–αž›αžŠαžαž›αŸαž αž™αž˜αž“αž‘αžΆαž˜

αž‘αžΆαžšαŸαž’αžΆαž™αž˜αžΆαž“αž‡αž“αžΆαž‰ αž“αž„ αž…αŸαž“αŸ‡αžŠαž„αž–αŸαžŸαžŸαžŽαžΆαž˜αž™αŸαž‘αŸ”

αŸαž“αŸ…αž€αž“αž„αž†αžΆαž“ ្០៑៦ UFCM αž‚αž‡αžΆαž˜αžΆαžŸαž“αŸ‚αžαž˜αž™αž‚αžαŸ‚αžŠαž›αŸαž‚αŸαžšαž”αžšαž”αžΆαžŸ

αžŸαžšαž˜αžΆαž”αŸαž’αžœαž€αžΆαžšαž–αž“αžαž™αŸ‚αžŠαž›αž”αžΆαž“αŸαžšαŸ€αž”αžšαžΆαž”αžαžΆαž„αŸαž› αŸ”

αžœαžΆαž˜αžΆαž“αžšαž”αž‡αžΆαžšαž”αž™αž—αžΆαž–αžαžΆαž› αž„ αž“αž„ αžšαžαžœαž”αžΆαž“αŸαž‚αž‘αž‘αž›αžŸαžΆαž‚ αž›αž‡αžœαž‰αž–αž—αž–

αŸαž›αžΆαž€ αŸ” αž˜αŸ‚αžŠαž›αžšαž”αžŸ UFCM αž˜αžΆαž“αžŠαž…αž‡αžΆ UF-100, UF-50,

UF-1000i, and UF-500αŸ” αžšαž‚αž”αŸαžŸαŸ€αžœαŸαž—αŸ…αŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαŸ‚αžŠαž›αž‘αžΆαž€αž‘αž„

αŸαž‘αŸ…αž“αž„αŸ‚αž•αž“αž€αžαžšαž˜αž„αŸαž“αžΆαž˜ αž‚αžŸαž‘αž’αŸ‚αžαž˜αžΆαž“αŸ‚αžŽαž“αžΆαž˜αžΆαžŸαž“αŸαž“αŸ‡αž‘αžΆαž„αž’αžŸ αŸ”

αž’αž“αž€αž“αž–αž“αž’αŸ‚αžŠαž›αž”αžΆαž“αž’αž—αžœαžŒαžαž“αžœαžœαž’αžŸαžΆαžšαžŸαžαŸαž“αŸ‡ αž“αž„αŸαž’αžœαž€αžΆαžšαž”αž€αžšαžŸαžΆαž™αž’αž–αžšαž”αžœ

αžαžαŸƒαž“αž€αžΆαžšαžšαžŸαžΆαžœαžšαž‡αžΆαžœαž’αž– hematuria αž€αžŠαž…αž‡αžΆαŸ‚αžŽαž“αžΆαž“αžœαžŠαŸαžŽαžšαž€αžΆαžšαž…αž”αžΆαžŸ

αž›αžΆαžŸαž€αž“αž„αž€αžΆαžšαž’αž—αžœαžŒαžαž˜αžΆαžŸαž“αžšαž”αžœαžαžαžŸαžΆαžšαžŸαžαŸαž“αŸ‡ αŸ”

[αž―αž€αžŸαžΆαžšαŸαž™αžΆαž„]1) Birch DF, Fairly KF: Haematuria: Glomerular or non-glomerular? Lancet 1979: ii: 845-846.2) Hyodo T, Kumano K, Sakai T: Differential diagno-sis between glomerular and nonglomerular hematuria by automated urinary flow cytometer. Nephron 1999: 82: 312-323.3) Apeland T, Mestad O, Hetland O: Assessment of hematuria: automated urine flowmetry vs microscopy.

Nephrol Dial Transplant: 2001: 16: 1615-1619.

Easy and Precise Detection of Glomerular and Non-Glomerular Hematuria by the Automated Urinary Flowcytometer : History of Development of the World-Wide Available Criteria

Toru Hyodo, M.D. and Ph.D.

1) Eijin Clinic and Kurata Hospital Dialysis Center, Hiratsuka, Japan2) Dept.of Urol., Kitasato University, Sagamihara, Japan3) NGO Ubiquitous Blood Purifi cation International, Yokohama, Japan

In 1979, Birch and Fairly [1] reported that urinary red blood cells (RBC) could be morphologically divided into glomerular and non-glomerular in origin under a phase contrast microscope. Their results were later by many studies and also introduced into famous textbooks as Campbell’s Urology and Smith’s General Urology. However classifi cation of urinary RBC under a light microscope depends on subjective visual assessment by human eyes, requires great skill, varies largely among different examiners and takes much time. For these reasons, it seemed to have not yet been introduced clinically and practically, although 20 years had passed after it was fi rst reported. The 1980’s and 1990’s were the years in which the objective and fast methods to detect glomerular and non-glomerular hematuria were desired and the international competitions were excited. In 1995, the automated urinary fl ow cytometer (UFCM) had been newly developed which utilize fl ow cytometry and an impedance method to detect urinary particles by Kitasato University Kidney Center & Sysmex Team in Japan. The main researcher in this project was Toru Hyodo, MD and PhD. The methodology was published on Nephron in 1999 [2]. And the precise verifi cation was performed by an European team [3] and UFCM was recognized to be useful as a means of

routine differential diagnosis of hematuria, and at least it was promising as a screening test to differentiate between glomerular and non-glomerular hematuria, because it can examine numerous samples within a short time and dose not necessitate any special skill and knowledge. In 2016, UFCM is the single machine to perform the above mentioned, popular and commercially available in all over the world. The series of UFCM have been named as UF-100, UF-50, UF-1000i, and UF-5000. Every textbook in nephrology and urology introduces this machine now in the world. The author who developed this methodology will present the history of hematuria research and introduce the precise process to develop this historical machine.

[Reference]1) Birch DF, Fairly KF: Haematuria: Glomerular or non-glomerular? Lancet 1979: ii: 845-846.2) Hyodo T, Kumano K, Sakai T: Differential diagnosis between glomerular and nonglomerular hematuria by automated urinary fl ow cytometer. Nephron 1999: 82: 312-323.3) Apeland T, Mestad O, Hetland O: Assessment of hematuria: automated urine fl owmetry vs microscopy. Nephrol Dial Transplant: 2001: 16: 1615-1619.

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016 7

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 20168 9

AbstractsAbstracts

Importance of engineering in dialysis therapy

Kenichi Kokubo 1,2,3)

1) Department of Medical Engineering and Technology, Kitasato University School of Allied Health Sciences,

2) Committee on International Affairs, Japanese Society for Technology of Blood Purifi cation, 3) NGO Ubiquitous Blood Purifi cation International

W. J. Kolff saved a patient with acute renal failure in 1945 by performing hemodialysis. This was the fi rst instance in which a life was saved by hemodi-alysis treatment. One of the reasons for this suc-cess was that the required peripheral technologies had been developed, such as mass production of cellophane membranes (1930s) and heparin (1920s) had been developed as an anticoagulant. However, more importantly, doctors and engi-neers collaboratively conducted research based on repeated experiments to determine the operating conditions and system confi guration. The fi rst home dialysis machine was also developed in 1965 by collaboration between doctors and engineers. Subsequently, mass production of dialyzers and dialysis machines by manufacturing companies, with important contributions from the engineer-ing fi eld, enabled us to treat many patients. The interdisciplinary fi eld between medicine and engineering was developed from such collabora-tion between the fi elds of medicine and engineer-

ing in clinical settings. The Clinical Engineer (CE) was born in Japan as a practitioner in this fi eld to provide safe and reliable treatment for patients using medical devices and technologies. In current dialysis therapy in Japan, the Clinical Engineer plays an important role in determining the oper-ating conditions and selecting the optimal dialyz-er for individual patients, because the solute re-moval effi ciency depends not only on the mass transfer effi ciency of the dialysis membrane, but also on operating conditions such as the blood fl ow rate and dialysate fl ow rate. The optimal prescrip-tion should be determined from the viewpoints of both medicine and engineering. Furthermore, the dialysis equipment should work correctly in every treatment session. To this end, daily checking and periodical maintenance and inspection are essen-tial. The importance of a technical perspective from an engineering point of view cannot be over-emphasized in past, current, or future dialysis therapy.

αžŸαžΆαžšαŸˆαžŸαžαžΆαž“αŸƒαž“αžœαžŸαžœαž€αžšαŸαž–αž‘αž™αž€αž“αž„αž€αžΆαžšαž–αž™αžΆαž”αžΆαž›αŸαžŠαžΆαž™αž€αžΆαžšαž›αžΆαž„αžˆαžΆαž˜

αŸαž›αžΆαž€αžŸαžΆαžšαžŸαžΆαž αž…αžΆαžšαž™ αŸαžαž„αž’αž‡ αžαž”αž€ (Kenichi Kokubo)

1) αž“αžΆαž™αž€αžŠαžΆαž‹ αž“αžœαžŸαžœαž€αž˜αž˜αŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαž“αž„αž”αŸαž…αž…αž€αžœαž‘αž™αžΆαŸƒαž“αžŸαžΆαž€αž›αžœαž‘αž™αžΆαž›αž™αžƒαžαžΆαžŸαžΆαž (Kitasato) αžŸαžΆαž›αžΆαžŸαž˜αž–αž“αž’αž˜αžαžαžœαž‘αž™αžΆαžŸαžΆαžšαžŸαžαžŸαžαžΆαž—αž”αžΆαž›,

2) αž‚αžŽαŸˆαž€αž˜αžΆαž˜ αž’αž€αžΆαžšαž€αž…αž…αž€αžΆαžšαž’αž“αžŠαžšαž‡αžΆαž, αžŸαž„αž‚αž˜ αžšαž”αžŸαžšαž”αŸαž‘αžŸαž‡αž”αž“αžŸαžšαž˜αžΆαž”αž”αŸαž…αž…αž€αžœαž‘αž™αžΆ αž€αž“αž„αž€αžΆαžšαž”αž“αžŸαž‘αž’αžˆαžΆαž˜,

3) (αž’αž„αž‚αž€αžΆαžšαŸαžšαž€αŸ…αžšαžŠαžΆαž‹ αž—αž”αžΆαž›) αž”αž“αžŸαž‘αž’αžˆαžΆαž˜αžšαž‚αž”αž‘αž€αŸ‚αž“αž›αž„αž‡αžΆαž’αž“αžŠαžšαž‡αžΆαž

αŸαž›αžΆαž€ W.J.Kolff αž”αžΆαž“αž‡αž™αž‡αžœαžαž’αž“αž€αž‡αž„αžαž…αžαžšαž˜αž„αŸαž“αžΆαž˜αž’αž„αž“αž’αž„αžšαž˜αž™αŸαž“αŸ…αž†αžΆαž“

1945αŸαžŠαžΆαž™αž€αžΆαžšαž›αžΆαž„αžˆαžΆαž˜ αŸ” αŸαž“αŸ‡αž‡αžΆαŸαž›αž€αžŠαž”αž„αŸαž αž™ αŸ‚αžŠαž›αž‡αžœαžαž˜αž™

αŸ‚αžŠαž›αžšαžαžœαž”αžΆαž“αž‡αž™αžŸαŸαžšαž„αžΆαž‚ αŸ‡αŸαžŠαžΆαž™αž€αžΆαžšαž–αž™αžΆαž”αžΆαž›αžαžΆαž˜αžšαž™αŸˆαž€αžΆαžšαž›αžΆαž„αžˆαžΆαž˜ αŸ”

αŸαž αžαž•αž›αž˜αž™αž€αž“αž„αž…αŸαžŽαžΆαž˜αŸαž αžαž•αž›αž‡αžΆαŸαžšαž…αž“αžŸαžšαž˜αžΆαž”αž—αžΆαž–αŸαž‡αžΆαž‚αž‡αž™αŸαž“αŸ‡

αžšαžαžœαž”αžΆαž“αŸαž‚αžŠαž„αžαžΆ αŸαžŠαžΆαž™αžŸαžΆαžšαŸ‚αžαž”αŸαž…αž…αž€αžœαž‘αž™αžΆαž€αž–αž™αž‘αžšαž˜αžΆαž“αž€αžΆαžšαžšαž€αž…αŸαžšαž“

αžŠαž…αž‡αžΆαž•αž›αžαž€αž˜αž˜αŸƒαž“αž—αžΆαž“ ស cellophane (αž†αžΆαž“ 1930) αž“αž„ heparin

(αž†αžΆαž“ 1920) αŸαžŠαž˜αž”αž•αž›αžαŸαž‘αŸ…αž‡αžΆαžαžΆαž“ αžŸαžšαž˜αžΆαž”αž‘αž”αžŸαžΆαž€ αžαž€αžΆαžšαž€αž€αžˆαžΆαž˜ αŸ”

αŸ‚αžαŸαž‘αžΆαŸ‡αž‡αžΆαž™αžΆαž„αžŽαžΆαž€αŸαžŠαžΆαž™ αž€αžαžΆαž αŸ‚αžŠαž›αžŸαžαžΆαž“αž‡αžΆαž„αŸαž‚αŸαž“αžΆαŸ‡αž‚αŸαžŠαžΆαž™αžŸαžΆαžšαŸ‚αž

αŸαžœαž‡αž‡αž”αžŽαžŒ αžαž“αž„αžœαžŸαžœαž€αžšαž”αžΆαž“αžšαž˜αžŸαž αž€αžΆαžšαž‚αžΆαž“ αŸαž’αžœαž€αžΆαžšαžšαžŸαžΆαžœαžšαž‡αžΆαžœ αŸαžŠαžΆαž™αŸ‚αž•αž’αž€αŸαž›

αž€αžΆαžšαž–αŸαžŸαžΆαž’αž“αž˜αžαž„αŸαž αž™αž˜αžαž„αŸαž‘αŸ€αž αŸαžŠαž˜αž”αž€αžŽαžαž›αž€αžαžαžŽαžŒ αŸƒαž“αž€αžΆαžšαž’αž“αžœαžαž

αž“αž„αž€αžΆαžšαž€αžŽαžαžšαž”αž–αž“αž’αŸαž•αžŸαž„αŸ— αžšαž”αžŸαž˜αžΆαžŸαž“αžŸαžšαž˜αžΆαž”αŸαž’αžœαž€αžΆαžšαž–αž™αžΆαž”αžΆαž› αŸ”

αž˜αžΆαžŸαž“αžŸαžšαž˜αžΆαž”αž›αžΆαž„αžˆαžΆαž˜αŸαž“αŸ…αž•αž‘αŸ‡ αžšαžαžœαž”αžΆαž“αž”αŸαž„αž€αžαŸαž‘αž„αž‡αžΆαŸαž›αž€αžŠαž”αž„αž•αž„

αŸ‚αžŠαžšαŸαž“αŸ…αž€αž“αž„αž†αžΆαž“ 1965 αŸαžŠαžΆαž™αž€αžΆαžšαžŸαž αž€αžΆαžšαž‚αžΆαž“ αžšαžœαžΆαž„αŸαžœαž‡αž‡αž”αžŽαžŒ αžαž“αž„αžœαžŸαžœαž€αžšαŸ”

αž”αž“αžΆαž‘ αž”αž˜αž€αŸαž‘αŸ€αž, αž€αžΆαžšαž•αž›αžαž‡αžΆαžšαž‘αž„αžšαž‘αžΆαž™αž’αŸƒαž“ dialyzers

αž“αž„αž˜αžΆαžŸαž“αž›αžΆαž„αžˆαžΆαž˜ αŸαžŠαžΆαž™αžšαž€αž˜αž αž“αž•αž›αžαŸαž•αžŸαž„αŸ—

αž‡αžΆαž˜αž™αž“αž„αž€αžΆαžšαžšαž˜αž…αŸ‚αžŽαž€αž™αžΆαž„αžŸαžαžΆαž“αž–αŸ‚αž•αž“αž€αžœαžŸαžœαž€αž˜αž˜αŸαž“αŸ‡ αž’αž“αž‰αžΆαž‰ αžαž±αž™αŸαž™

αž„αž–αž™αžΆαž”αžΆαž›αž’αž“αž€αž‡αž„αž”αžΆαž“αž‡αžΆαŸαžšαž…αž“αž‡αžΆαž„αž˜αž“αž”αŸ‚αž“αžαž˜αŸαž‘αŸ€αž αŸ”

αž€αžΆαžšαž…αŸ‡αŸαž’αžœαž€αž˜αž˜αžŸαž€αžŸαžΆαžšαžœαžΆαž„αŸ‚αž•αž“αž€αŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαž“αž„αžœαžŸαžœαž€αž˜αž˜ αžšαžαžœαž”αžΆαž“αž’αž—αžœαžŒαžαŸαžŠαžΆ

αž™αž€αžΆαžšαžŸαž αžšαž”αžαž”αžαžαž€αžΆαžšαž‚αžΆαž“ αžšαžœαžΆαž„αžœαžŸαž™αŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαž“αž„αžœαžŸαž™αžœαžŸαžœαž€αž˜αž˜ αŸαž“αŸ…αž€αž“αž„

αŸαž‚αžΆαž›αž”αžŽαž„αž‡αžšαž‰αž€αžΆαžšαž–αž™αžΆαž”αžΆαž›αŸαž’αžΆαž™αž˜αžΆαž“αž—αžΆαž–αžšαž”αŸαžŸαžšαž‡αžΆαž„αž˜αž“ αŸ”

αžœαžŸαžœαž€αžšαŸαžœαž‡αž‡αžŸαžΆαžšαžŸαž (CE) αž”αžΆαž“αŸαž›αž…αŸαž‘αž„αŸαž“αŸ…αžšαž”αŸαž‘αžŸαž‡αž”αž“αž€αž“αž„

αž“αžΆαž˜αž‡αžΆαž’αž“αž€αž’αž“αžœαžαžαŸαž“αŸ…αž€αž“αž„αŸ‚αž•αž“αž€αŸαž“αŸ‡αŸαžŠαž˜αž”αž•αžαž›αž€αžΆαžšαž–αž™αžΆαž”αžΆαž›αŸ‚αžŠαž›αž˜αžΆαž“αžŸαžœαžαž

αž—αžΆαž–αž“αž„αž’αžΆαž…αŸαž‡αžΏαž‘αž€αž…αžαžαž”αžΆαž“αžŠαž›αž’αž“αž€αž‡αž„αŸαžŠαžΆαž™αŸαžšαž”αž§αž”αž€αžšαžŽαŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαž“

αž„αž”αŸαž…αž…αž€αžœαž‘αž™αžΆαŸ” αž“αžΆαŸαž–αž›αž”αž…αž…αž”αž”αž“αž“ αž€αžΆαžšαž–αž™αžΆαž”αžΆαž›αŸαžŠαžΆαž™αž€αžΆαžšαž›αžΆαž„αžˆαžΆαž˜

αŸαž“αŸ…αž€αž“αž„αžšαž”αŸαž‘αžŸαž‡αž”αž“ αžœαžŸαžœαž€αžšαŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαŸαžŠαžšαžαž“αžΆαž‘αž™αžΆαž„αžŸαžαžΆαž“ αž€αž“αž„αž€αžΆαžš

αž€αžŽαžαž›αž€αžαžαžŽαžŒ αžšαž”αžαž”αžαžαž€αžΆαžšαž“αž„αŸαžšαž‡αžŸαŸαžšαžŸ dialyzer αŸ‚αžŠαž›αž›αž’αžšαž”αŸαžŸαžšαž”

αž•αžαžŸαžšαž˜αžΆαž”αž’αž“αž€αž‡αž„αž˜αžΆαž“ αž€αŸ— αŸ” αŸαž“αžΆαŸ‡αž‚αŸαžŠαžΆαž™αžŸαžΆαžšαŸ‚αž αžŠαŸαžŽαžΆαŸ‡αžšαžŸαžΆαž™αž€αž“αž„

αž€αžΆαžšαž™αž€αŸαž…αž‰αžŠαž˜αžΆαž“αžšαž”αžŸαž‘αž’αž—αžΆαž–αž˜αž“αž’αžΆαžšαžŸαž™αžšαžαž˜αŸ‚αž αžšαž”αžŸαž‘αž’αž—αžΆαž–αŸƒαž“αž€αžΆαžš

αŸαž•αž‘αžšαž—αžΆαž“ αžŸαž›αžΆαž„αžˆαžΆαž˜αž’αŸαž“αŸ‡αŸαž‘ αž”αŸ‚αž“αžαŸαž“αŸ…αŸαž›αž›αž€αžαžαžŽαžŒ αžšαž”αžαž”αžαžŠαž€αžΆαžš αžŠαž…αž‡αžΆ

αž’αžšαžαžΆαž›αž αžšαžˆαžΆαž˜αž“αž„αž’αžšαžαžΆαž›αž αžšαŸƒαž“ dialysate αž•αž„αŸ‚αžŠαžš αŸ”

αŸαžœαž‡αž‡αž”αž‰αžΆαž‡ αŸ‚αžŠαž›αž›αž’αž”αž•αž αž‚αžšαŸ‚αžαžšαžαžœαž”αžΆαž“αž€αžŽαžαŸαž…αž‰αž–αž‘αžŸαžŸαž“αŸˆαž‘αžΆαž„αŸ‚αž•αž“αž€αŸαžœαž‡αž‡

αžŸαžΆαžšαžŸαžαž“αž„αžœαžŸαžœαž€αž˜αž˜ αŸ” αŸαž›αžŸαž–αŸαž“αŸ‡αŸαž‘αŸ€αž αž§αž”αž€αžšαžŽαž›αžΆαž„αžˆαžΆαž˜αž‚αžšαŸ‚αžαž˜αžΆαž“

αžŠαŸαžŽαžšαž€αžΆαžšαž™αžΆαž„αžšαžαž˜αžšαžαžœαžšαž‚αž”αž€αžΆαžšαž–αž™αžΆαž”αžΆαž›αž‘αžΆαž„αž’αžŸαŸ” αž‡αžΆαž…αž„αŸαžšαž€αžΆαž™

αž€αžΆαžšαžšαžαžαž–αž“αžαž™ αž“αž„ αž€αžΆαžšαŸ‚αžαž‘αžΆαž‡αžΆαžšαž”αž…αžΆαž‚αž˜αžΆαž“αžŸαžΆαžšαŸˆαžŸαžαžΆαž“αžŽαžΆαžŸ αŸ”

αŸαž“αŸ…αž€αž“αž„αž€αžΆαžšαž–αž™αžΆαž”αžΆαž›αŸαžŠαžΆαž™αž€αžΆαžšαž›αžΆαž„αžˆαžΆαž˜ αŸαž™αž„αž˜αž“αž’αžΆαž…αŸαž˜αž›αžšαž›αž„αž‘αžŸαžŸαž“αŸˆ

αžœαžŸαžŸαž™αžšαž”αžŸαžœαžŸαžœαž€αžšαŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαž”αžΆαž“αŸαž‘αž™ αŸαž‘αžΆαŸ‡αž”αž‡αžΆαž’αžαžαž€αžΆαž› αž”αž…αž…αž”αž”αž“αž“

ឬ αž’αž“αžΆαž‚αžαž€αŸαžŠαžΆαž™ αŸ”

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 201610 11

αž’αžαžαž“αž™αŸƒαž“αž€αžΆαžšαŸαž€αž“αŸαž‘αž„αž‘αž„αž“αž…αŸαž“αžΆαž› αŸ‡αŸαž–αž›αž›αžΆαž„αžˆαžΆαž˜ αŸ– αž€αžΆαžšαŸαž‘αž„αž‘αž„αž“1Kg αŸαžŸαž˜αž“αž„αž€αžΆαžšαž‘αž‘αž›αž‘αžΆαž“αž‡αžΆαžαž’αž”αž›αžšαž”αŸ‚αž αž› 8g αŸ”

αŸαž›αžΆαž€αžŸαžΆαžšαžŸαžΆαž αž…αžΆαžšαž™ αŸαžαž„αž’αž‡ αžαž”αž€ (Kenichi Kokubo)

1) αžšαž”αž’αžΆαž“αž‚αž›αž“αž€αŸαž’αž™αž™αž“ (Eijin) αž“αž„ αž˜αž“αž‘αžšαŸαž–αž‘αž™αž“αž„αž˜αž‡αžˆαž˜αžŽαžŒ αž›αž›αžΆαž„αžˆαžΆαž˜αžƒαžšαžΆαžαžΆ (Kurata), αž‘αžšαž€αž„αž αžšαžΆαžŸαžŸαž€αžΆ (Hiratsuka) αžšαž”αŸαž‘αžŸαž‡αž”αž“

2) αžŸαžΆαž€αž›αžœαž‘αž™αžΆαž›αž™αž±αžŸαžαžŸαžΆαžšαžŸαž αžƒαžαžΆαžŸαžΆαž αŸ‚αž•αž“αž€αžαžšαž˜αž„αŸαž“αžΆαž˜ αž‘αžšαž€αž„αžŸαžΆαž€αžΆαž αžΆαž€ មហអរអ αžšαž”αŸαž‘αžŸαž‡αž”αž“

3) αž˜αž‡αžˆαž˜αžŽαžŒ αž›αž›αžΆαž„αžˆαžΆαž˜ αž˜αžαžαž—αžΆαž–αž€αž˜αž–αž‡αžΆ - αž‡αž”αž“ αŸƒαž“αž˜αž“αž‘αžšαŸαž–αž‘αž™αžŸαžΆαž€αž›αžœαž‘αž™αžΆαž›αž™αž’αž“αžαžšαž‡αžΆαž αŸ‚αžŸαž“αžŸαž, αž—αž“αŸαž–αž‰ αžšαž”αŸαž‘αžŸαž€αž˜αž–αž‡αžΆ αŸ”

αž˜αž“αž‘αžšαŸαž–αž‘αž™αž™αž€αž αžΆαž˜αžΆ (Yokohama)αž‘1 αŸ‚αž•αž“αž€αžαžšαž˜αž„αŸαž“αžΆαž˜

សអរសអត αž…αžΆαžšαž™αŸαžšαž€αŸ…αŸαž˜αžΆαž„αŸƒαž“ αžŸαžΆαž€αž›αžœαž‘αž™αžΆαž›αž™αžƒαžαžΆαžŸαžΆαž (Kitasato) αŸ‚αž•αž“αž€αžαžšαž˜αž„αŸαž“αžΆαž˜

សអរសអត αž…αžΆαžšαž™αŸαžšαž€αŸ…αŸαž˜αžΆαž„αŸƒαž“ αžŸαžΆαž€αž›αžœαž‘αž™αžΆαž›αž™αž“αžΆαžšαžŸαžΆαž αžΆαž€ ម (Sagami) αŸ‚αž•αž“αž€αž’αžΆαž αžΆαžšαžšαž”αžαžαž˜αž—

αž αž™αžŠ ថរ (Hyodo Toru)

αžαž“αž„αžŸαžšαŸαžŸαžšαž’αžαžαž”αž‘αž‘αžΆαž„αŸαž“αŸ‡αŸαž‘αŸ…αž€αž“αž„ αž‘αžŸαžŸαž“αžΆαžœαžŠαž Cambodian Journal of Nephrology αž…αžΆαž”αž–αž—αžΆαž‚αž‘αŸ‘ αŸαž“αŸ‡αžαŸαž‘αŸ… αŸ” αŸαž“αŸ…αž€αž“αž„αž’αžαžαž”αž‘αŸαž“αŸ‡

αžαž“αž„αŸ‚αžŽαž“αžΆαŸαžšαžΏαž„αžšαžΆαžœαž˜αž™αž…αž“αž“αŸ‚αžŠαž›αžŸαž˜αž”αŸ‚αžαž“αžΆαž―αžšαž”αŸαž‘αžŸαž‡αž”αž“ αž’αž“αž€αž‡αž„αŸ‚αžŠαž›αž˜αžΆαž“αž”αž‘αž–αŸαžŸαžΆαž’αž“αž›αžΆαž„αžˆαžΆαž˜αž™αžšαž˜αž€αŸαž αž™αž€αŸαžŠαžΆαž™αž€αž˜αž“αž’αžΆαž› αž”αž”αžΆαž“αžŠαž„ αŸ”

[αž€αžΆαžšαŸαž€αž“αž‘αž„αž“αž…αŸαž“αžΆαž› αŸ‡αŸαž–αž›αž›αžΆαž„αžˆαžΆαž˜αž‚αž˜αž“αŸ‚αž˜αž“αŸαžŠαžΆαž™αžŸαžΆαžšαž”αžšαž˜αžΆαžŽαž’αžΆαž αžΆαžšαŸ‚αžŠαž›αŸαž™αž„αž”αžΆαž“αž‘αž‘αž›αž‘αžΆαž“αŸαž“αžΆαŸ‡αŸαž‘ αž‚αž‡αžΆαž”αžšαž˜αžΆαžŽαŸƒαž“αž‘αž€ ឬ αŸ‚αž

αŸ‚αžŠαž›αž”αžΆαž“αž‘αž‘αž›αž‘αžΆαž“αž…

αŸαž“αžΆαž› αŸ‡αŸαž–αž›αž›αžΆαž„αžˆαžΆαž˜αŸαž‘αŸ…αžœαž‰αŸαž‘] αŸ” αž”αžšαž˜αžΆαžŽαŸƒαž“αžŸαžΆαžšαž’αžΆαžαž‘αž€αŸ‚αžŠαž›αž˜αžΆαž“αŸαž“αŸ…αž€αž“αž„αž”αžΆαž™ αžŸαžΆαž… រត ឬ αž”αŸ‚αž“αž›αž‡αžΆαŸαžŠαž˜ (800mL) αž“αž„αž‡αžΆαžαž‘αž€

(200mL) (αŸ‚αžŠαž›αŸαž€αžαŸαž…αž‰αž–αž€αžΆαžšαž”αŸ‚αž›αž„αž’αžΆαž αžΆαžšαŸ‚αžŠαž›αž”αžΆαž“αž‘αž‘αž›αž‘αžΆαž“αŸαž‘αŸ…αž‡αžΆαžαžΆαž˜αž–αž›) αžŸαžšαž”αž€αž“αž„αž˜αž™αŸƒαžαž„αžšαž”αŸ‚αž αž›αž‡αžΆ 1αž›αžšαž αŸ” αž€αž”αŸ‚αž“αžαžœαžΆαž€αžšαžαžœαž”αžΆαž“αž”

αŸαž‰αž…αž‰αŸαž‘αŸ…αžœαž‰αžαžΆαž˜αžšαž™αŸˆαŸαž‰αžŸ αž“αž„αžαž™αž›αžŠαŸαž„αž αž˜αŸαž…αž‰ (800mL) αž“αž„ αž‘αž€αŸαž“αžΆαž˜ (200mL) αŸ” αžŠαŸαž…αž“αŸ‡αž˜αžΆαž“αž“αž™αžαžΆ αŸαž“αŸ…αžŸαž›αŸ‚αžαž”αžšαž˜αžΆαžŽαž‘αž€αŸ‚αžŠαž›

αŸαž™αž„αž”αžΆαž“αž‘αž‘αž›αž‘αžΆαž“αž”αŸ‚αž“αžαž˜αŸ‚αžαž”αŸαžŽαžΆαžŽ αŸ‡ αŸ‚αžŠαž›αŸαž’αžœαŸαž’αžΆαž™αŸαž€αž“αŸαž‘αž„αŸƒαž“αž‘αž„αž“αž…αŸαž“αžΆαž› αŸ‡αŸαž–αž›αž›αžΆαž„αžˆαžΆαž˜αŸαž“αžΆαŸ‡ αŸ” αŸαžŠαžΆαž™αžŸαžΆαžšαž˜αž›αŸαž αžαžαžΆαž„αŸαž›αŸαž“αŸ‡αŸαž αž™

αŸαž‘αž”αŸαž™αž„αž…αžΆαžαž‘αž€αžαžΆ αž‘αž„αž“αŸ‚αžŠαž›αŸαž€αž“αŸαž‘αž„αŸαžšαž€αžΆαž™αž€αžΆαžš αž›αžΆαž„αžˆαžΆαž˜αž‚αž‡αžΆαž”αžšαž˜αžΆαžŽαž‘αž€ αŸ” αž”αžšαž˜αžΆαžŽαž‘αž€αž‘αžΆαž„αŸαž“αžΆαŸ‡αž“αž„αžšαžαžœαž”αŸαž‰αž…αž‰αŸαž‘αŸ…αžœαž‰αžαžΆαž˜αžšαž™αŸˆαž€αžΆαžšαž›αžΆ

αž„αžˆαžΆαž˜ αŸ”

αž”αž“αžΆαž‘ αž”αž˜αž€αŸαž‘αŸ€αž αž‚αž€αŸαžŽαž“αŸƒαž“αž”αžšαž˜αžΆαžŽαž’αž”αž›αŸ‚αžŠαž›αŸαž€αž“αž‡αžΆαž˜αž™αž“αž„αž‘αž„αž“αžšαžΆαž„αž€αžΆαž™ (=αž”αžšαž˜αžΆαžŽαž‘αž€) αž…αŸαž“αžΆαž› αŸ‡αŸαž–αž›αž›αžΆαž„αžˆαžΆαž˜ αŸ” αž”αžšαž˜αžΆαžŽαž€αž αžΆαž”αŸƒαž“αž’

αž”αž›αŸ‚αžŠαž›αž˜αžΆαž“αŸαž“αŸ…αž€αž“αž„αžšαžΆαž„αž€αžΆαž™αžšαž”αžŸαž’αž“αž€αž‡αž„αž›αžΆαž„αžˆαžΆαž˜αžšαž”αŸ‚αž αž›αž“αž„ 140mEq/L αŸ” αŸαž™αž„αž’αžΆαž…αŸαž’αžœαž€αžΆαžšαž‚αžŽαž“αžΆαžαžΆαž˜αžœαž’αžαžΆαž„αŸαžšαž€αžΆαž˜αž”αžΆαž“ αŸ–

αž”αžšαž˜αžΆαžŽαž‘αž„αž“αŸ‚αžŠαž›αŸαž€αž“ (αž”αžšαž˜αžΆαžŽαž‘αž€αž€αž“αž„1αž›αžšαž) Γ— 140 Γ— αž‘αž˜αž„αž“αž˜αŸαž›αž‚αž›αž’αž”αž› (58.5) /1000= αž”αžšαž˜αžΆαžŽαž‘αž„αž“αŸ‚αžŠαž›αŸαž€αž“(Kg) Γ— αžšαž”αŸ‚αž αž› 8g

αžŠαŸαž…αž“αŸ‡ αŸαž™αž„αž’αžΆαž…αŸαž’αžœαž€αžΆαžšαž‚αžŽαž“αžΆαŸαžŠαžΆαž™αž™αž€αž‘αž„αž“ 1Kg (αž‘αž€1αž›αžšαž) αŸαžŸαž˜αž“αž„αž€αžΆαžšαž‘αž‘αž›αž‘αžΆαž“αž‡αžΆαžαž’αž”αž›αžšαž”αž˜αžΆαžŽ 8g αž”αžΆαž“ αŸ”

αŸαž›αžΆαž€A αŸ‚αžŠαž›αž‡αžΆαž’αž“αž€αž‡αž„αžšαž”αžŸαžαž˜αžΆαž“αž‘αž„αž“ 50Kg αŸ” αžαž›αž“αž‚αžΆαžαž•αžΆαž‘ αž›αž‚αžαžαžΆ αžαž›αž“αž˜αž“αž”αžΆαž“αž‘αž‘αž›αž‘αžΆαž“αž‡αžΆαžαž’αž”αž›αŸαž“αžΆαŸ‡αŸαž‘ αž€αž”αŸ‚αž“αžαž‡αžΆαž€αŸ‚αžŸαžαž„

αž‚αžΆαžαž”αžΆαž“αŸαž‘αž„αž‘αž„αž“αžšαž”αŸ‚αž αž› 4Kg αŸαžšαŸ€αž„αžšαžΆαž›αž€αžΆαžšαžαž›αž„αž‘αž˜αž„αž“αž“αžΆαŸƒαžαž„αž…αž“αž‘ αŸ” αŸαžšαž€αžΆαž™αž–αž αž–αž“αž™αž›αž‚αžΆαžαž–αžšαŸαž”αŸ€αž”αž‚αžŽαž“αžΆαžαžΆαž„αŸαž›

αž‚αžΆαžαŸ‚αžαž„αŸ‚αžαŸαž’αžœαž€αžΆαžšαž‚αžŽαž“αžΆαžŸαžΆαžšαž‡αžΆαžαž’αž”αž›αŸ‚αžŠαž›αž‚αžΆαžαž‘αž‘αž›αž‘αžΆαž“αž‡αžΆαŸαžšαŸ€αž„αžšαžΆαž›αŸƒαžαž„αŸαžšαž€αžΆαž™αž–αž”αž‰αž…αž”αž€αžΆαžšαž›αžΆαž„αžˆαžΆαž˜ αŸαž αž™αž‚αžΆαžαž€αŸƒαž›αžαžšαž˜αžœαž”αžšαž˜αžΆαžŽαž’αžΆαž αžΆαžšαŸ‚αžŠ

αž›αž‚αžšαž”αžšαŸαž—αžΆαž‚ αŸ” αž‡αžΆαž›αž‘αž’αž•αž› αž‚αžΆαžαž”αž“αžαž™αž€αžΆαžšαŸαž‘αž„αž‘αž„αž“αž˜αž€αžšαžαž˜ 2.5Kg (αž‡αžΆαžαž‘αž€ 2.5 αž›αžšαž) αŸ”

αžαžΆαž„αŸαž›αŸαž“αŸ‡ αž‚αž‡αžΆαž§αž‘αžΆαž αžšαžŽαžšαž”αžŸαž’αž“αž€αž‡αž„αŸ‚αžŠαž›αž˜αž“αž’αžΆαž…αž”αŸαž‰αž…αž‰αž‘αž€αŸαž“αžΆαž˜αž”αžΆαž“αž‘αžΆαž›αŸ‚αžαŸαžŸαžΆαŸ‡ αŸ” αž€αž“αž„αž€αžšαžŽαž’αž“αž€αž‡αž„αž’αžΆαž…αž”αŸαž‰αž…αž‰αž‘αž€αŸαž“αžΆαž˜αž”αžΆαž“αžαž›αŸ‡αŸαž“αžΆαŸ‡

αŸαž“αŸ…αž€αž“αž„αž‘αž€αŸαž“αžΆαž˜ 1αž›αžšαžαž‚αžšαž˜αž•αžŸαŸαž‘αŸ…αŸαžŠαžΆαž™αžŸαžΆαžšαž’αžΆαžαž’αž”αž› 5g αŸ” αŸαž™αž„αž’αžΆαž…αŸαž’αžœαž€αžΆαžšαž‚αžŽαž“αžΆαžœαžΆαž”αŸ‚αž“αžαž˜αž”αžΆαž“ αŸαžšαž–αžΆαŸ‡αŸαž“αŸ…αž€αž“αž„αž€αžΆαžšαž–αŸαžŸαžΆαž’αž“αžšαž”αžŸαžαž“αžΆαž―αžšαž”

αŸαž‘αžŸαž‡αž”αž“αž”αžΆαž“αž”αž—αž›αžšαž…αž˜αž€αŸαž αž™ αŸ”

αžŸαž˜αž’αž“αž€αž‘αžΆαž„αž’αžŸαž‚αžΆαž“ αžŸαžΆαž€αž›αž”αž„αžœαž’αž‚αžŽαž“αžΆαŸαž“αŸ‡αž‘αžΆαž„αž’αžŸαž‚αžΆαž“ αŸ”

Signifi cance of the inter-dialytic weight gain: A 1-kg increase corresponds to the consumption of 8 g of salt.

Toru Hyodo, M.D. and Ph.D

1) Director, Eijin Clinic and Kurata Hospital Dialysis Center, Hiratsuka, Japan2) Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan3) Cambodia-Japan Blood Purifi cation Center, Sen Sok International University Hospital, Phnom Penh, Cambodia

I will start this column from the 1st volume of the Cambodian Journal of Nephrology.In this article, I will introduce matters that experienced patients may not know.[An increase in the body weight between dialysis points is equivalent to the total weight of water, tea, and juice consumed between dialysis points, but not to the food weight.]The sum of daily water intake (approximately 800 mL) from foods, such as rice, meat, fi sh, and vegeta-bles, and metabolic fl uid production (fl uid generated in the process of food utilization as energy in vivo)(approximately 200 mL) is approximately 1,000 mL. This is equivalent to the sum of sweat/expired air water excretion (800 mL) and fecal water excretion (200 mL).Briefl y, total water intake (weight) is equivalent to an increase in the body weight between dialysis points. For this reason, the rate of increase in the body weight measured before dialysis is regarded as water retention. Water removal at this volume is performed on dialysis.Next, the increase in the volume of salt contained in the body weight (=water volume) between dialysis points can be calculated using the following formula based on the in vivo concentration of salt in patients undergoing dialysis (approximately 140 mEq/L): Rate of increase in the body weight (Kg) Γ— 140 Γ— mo-lecular weight of salt (58.5)/1,000 = Rate of increase in the body weight (Kg) Γ— approximately 8 g.In other words, the formula means the consumption of salt at approximately 8 g per kg body weight (water retention in L).Patient A (dry weight: 50 kg) had shown a 4-kg increase in the body weight in the morning on Mondays despite restricted salt intake. After this formula was given, Patient A measured the body weight at the same hour (for example, at 2 o’clock P.M.) on the completion of dialysis every day, and calculated salt intake to assess whether it was appropriate. As a result, it became possible to reduce the rate of increase in the body weight to 2.5 kg (2.5 L water retention).The above patient had anuria. In patients with urination, 5 g of salt per one litter may be contained in urine. My previous study in Japan indicated the merits of additional calculation.Please introduce this formula to patients and utilize it.

Dialysis Column

Γ— Γ— Γ—

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 201612 13

Author Guidelines

1. The Cambodian Journal of Nephrology (hereinafter referred to as β€œJournal”) is an English/Cambodian/Japanese language journal published by Reiseikai Media (Cambodia) Co., Ltd (β€œCompany”). The purpose of the Journal is to widely introduce medical achievements in the fi elds of basic and clinical medicine on nephrology and thereby to contribute to the develop-ment of medicine and human beings.

2. Authors are requested to understand and accept to the content of this author guideline (here-inafter referred to as β€œGuideline”) before submitting manuscripts to the Journal. The Guide-line may be revised from time to time at the sole discretion of the Company.

3. Copyrights of the submitted manuscripts will, in principle, remain with the authors, provided, however, that during the effective period of copyrights and throughout the world, the Compa-ny has the non-exclusive right to reproduce, distribute and transmit to the public, all or part of the copies of the manuscripts, as well as the non-exclusive right to translate, proofread or adapt them to the extent necessary to post in the Journal. Where the copyright of the submit-ted manuscript belongs to someone other than the person who has submitted to the Journal, the person who has submitted shall obtain a prior approval from the copyright owner for sub-mitting the manuscript to the Journal according to the Guideline.

4. Copyrights in any work of translation, proofreading or any other adaptation conducted by the Company on the submitted manuscripts will belong to the Company. The authors may not, without a prior written consent of the Company, use such works in any medium other than the Journal, notwithstanding section 28 of the Japanese Copyrights Act and its counterpart provi-sion of a law of the relevant countries.

5. Authors must not make any objection to the translation, proofreading or any other adaptation conducted by the Company to the submitted manuscripts.

6. Authors must warrant that the submitted manuscripts would not infringe any third party’s copyrights, moral rights including rights in relation to privacy and defamation or any other rights. Clinical researches must have been performed according to the Declaration of Helsinki and ethical consideration must have been fully taken into. Experiments involving animals must have been conducted in the manner giving careful consideration to animal protection. Where the content of the submitted manuscripts involves interest of particular individuals or organizations/bodies, authors are requested to expressly write down such interest or possible confl ict of interest in the text of the manuscripts.

7. Manuscripts acceptable to be submitted are not limited to those that are not yet submitted to or published in, the other journals or academic societies etc. If, however, authors intend to submit to the Journal, manuscripts that contain substantially the same part(s) of the content of those which are already submitted to or published in, other journals or academic societies etc., authors are requested to, including but not limited to, look up the author guidelines of the journals or members’ rules of the academic societies etc.; make inquiries to the journals or

academic societies etc. in advance where necessary; and obtain approvals for citation or repro-duction, so as to avoid any violation of ethics as researchers. Authors are requested to state citations (name of author, name of book, year of publication, page number etc.) in the text of the manuscripts where suitable.

8. The Journal does not prohibit authors from submitting the same manuscripts to other journals. However, the authors must understand and accept that under the authors guideline of other journals, submission to the Journal of a manuscript might cause prohibition of the same man-uscript from being submitted to other journals; and that in case where the authors are not al-lowed to submit a manuscript to other journals because the same manuscript has been submit-ted to the Journal, the Company will not owe any liability at all to the authors for posting the manuscript in the Journal.

9. Whether or not to post in the Journal the manuscripts submitted will be decided by the Editing Committee after the peer review by peers designated by the Editing Committee.

10. The manuscripts submitted to the Journal will not, in principle, be returned to the authors.

11. Proofreading by an author will be allowed only with the fi rst proof, and the author must return the manuscript by the due date requested. The proofreading by an author will be allowed only as to corrections of omission of letters and typographers, and no additional writing to the manuscript in the proofreading is, in principle, permitted.

12. 1) Manuscripts to be submitted must be prepared using computer software.2) Manuscripts must be in horizontal writing with appropriate spaces between the lines on

A4 size papers.

13. Neither the Company nor authors whose manuscripts have been posted in the Journal will not be paid for the publication of them.

14. Manuscripts must be submitted to the following:

Reiseikai Media (Cambodia) Co., Ltd.18/F Canadia Tower, No. 315, Ang Doung St,

Corner Monivong Blvd, Phnom Penh,Cambodia

E-mail: [email protected]

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 201614 15

αž”αž‘αž”αž”αž‰αž‰αžαžαž‡αžΆαž•αž› αžœαž€αžΆαžšαŸƒαž“αž€αžΆαžšαž…αŸ‡αž•αžŸαžΆαž™ 1. αž‘αžŸαžŸαž“αžΆαžœαžŠαž The Cambodian Journal of Nephrology αžšαžαžœαž”αžΆαž“αŸαž”αžΆαŸ‡αž–αž˜αž–αž•αžŸαžΆαž™αž‡αžΆαž—αžΆαžŸαžΆαŸ‚αžαž˜αžš αž’αž„αŸαž‚αž›αžŸ

αž“αž„ αž‡αž”αž“αŸαžŠαžΆαž™αžšαž€αž˜αž αž“ Reiseikai Media (Cambodia) Co.,Ltd. αž€αž“αž„αŸαž‚αžΆαž›αž”αžŽαž„αžšαž˜αž…αŸ‚αžŽαž€αž€αž“αž„

αžœαžŸαž™αŸαžœαž‡αž‡αžŸαžΆαžšαžŸαž αž€αžŠαž…αž‡αžΆαž€αžΆαžšαž’αž—αžœαžŒαžαž’αž“αž’αžΆαž“αž˜αž“αžŸαžŸαžαžΆαž˜αžšαž™αŸˆαž€αžΆαžšαŸ‚αžŽαž“αžΆαž–αž˜αž›αžŠαžΆαž‹ αž“αžšαž‚αŸ‡αŸƒαž“αž‡αž„αžαžšαž˜αž„αŸαž“αžΆαž˜ αž“αž„

αžŸαž˜αž‘αž’αž•αž›αŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαž€αž“αž„αžœαžŸαž™αžŸαžαžΆαž—αž”αžΆαž›αŸαž’αžΆαž™αž”αžΆαž“αž‘αž›αž‘αž›αž›αžΆαž™αž•αž„αŸ‚αžŠαžš αŸ”

2. αž’αž“αž€αž“αž–αž“αž’ αžšαžαžœαž™αž›αž…αž”αžΆαžŸ αž“αž„ αž‘αž‘αž›αžŸαžΆαž‚ αž›αž”αž‘αž”αž”αž‰αž‰αžαžαŸƒαž“αž€αžΆαžšαž…αŸ‡αž•αžŸαžΆαž™αŸαž“αŸ‡ αŸ” αžŸαž˜αž…αžŽαžΆαž•αž„αŸ‚αžŠαžšαžαžΆ

αž”αž‘αž”αž”αž‰αž‰αžαžαŸαž“αŸ‡ αž’αžΆαž…αž“αž„αžšαžαžœαž”αžΆαž“αŸαž’αžœαžœαŸαžŸαžΆαž’αž“αž€αž˜αž˜αžαžΆαž˜αž€αžΆαžšαžŸαŸαžšαž…αž…αžαžαžšαž”αžŸαŸαž™αž„αž αŸ”

3. αžšαžΆαž›αžŸαžΆαžšαžŽαžΆαž‘αžΆαž„αž’αžŸ αŸ‚αžŠαž›αž”αžΆαž“αž…αŸ‡αž•αžŸαžΆαž™αž‡αžΆαž˜αž™αŸαž™αž„αžαžšαžαžœαž”αžΆαž“αžšαž€αžŸαžΆαžŸαž‘αž’αŸαžŠαžΆαž™ αž’αž“αž€αž“αž–αž“αž’ αŸ” αž€αž”αŸ‚αž“αž αžšαž€αž˜αž αž“

αŸαž™αž„αžαž“αž„αž‘αž‘αž›αž”αžΆαž“αž“αžœαžŸαž‘αž’αŸαž’αžœαž€αžΆαžšαžαžαž…αž˜αž›αž„ αŸ‚αž…αž€αž…αžΆαž™ αŸαž•αž‰αžšαž‡αžΆαžŸαžΆαž’αžΆαžšαžŽαŸˆ αž”αž€αŸ‚αžšαž” αž“αž„αŸ‚αž€αžŸαžšαž˜αž›αŸαž•αžŸαž„αŸ—

αž”αžΆαž“αž‘αž‘αžΆαž„αž–αž—αž–αŸαž›αžΆαž€ αž€αž“αž„αž€αž‘αž„αŸαž–αž›αŸ‚αžŠαž›αž”αžΆαž“αžšαž–αž˜αŸαžšαž–αŸ€αž„αž˜αž™ αŸ” αŸαž™αžΆαž„αŸαž‘αŸ…αžαžΆαž˜αž”αž‘αž”αž‰αž‰αžαž αž€αž“αž„αž€αžšαžŽαŸ‚αžŠαž›

αž’αž“αž€αž“αž–αž“αž’ αž…αž„αž•αžαž›αžŸαž‘αž’αž“αž–αž“αž’αŸαž’αžΆαž™αž’αž“αž€αžŠαŸƒαž‘ αžšαžαžœαž˜αž€αžŸαž€αžΆαžšαž’αž“αž‰αžΆαž‰ αžαž–αžšαž€αž˜αž αž“αŸαž™αž„αž‡αžΆαžαž˜αž“αžŸαž“ αŸ”

4. αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αžšαžαžœαž”αžΆαž“αž”αž€αŸ‚αžšαž” αž“αž„ αŸ‚αž€αžŸαžšαž˜αž›αŸαžŠαžΆαž™αžšαž€αž˜αž αž“αŸαž™αž„αžαž“αž„αžšαžαžœαž”αžΆαž“αžšαž€αžŸαžΆαžŸαž‘αž’αžšαž‚αž”αž™αžΆαž„αŸαžŠαžΆαž™

αžšαž€αž˜αž αž“αŸαž™αž„αž αŸ” αž˜αžΆαžšαžαžΆαž‘αŸ’αŸ¨αžŸαžαž–αž…αž”αžΆαž”αžšαž€αžŸαžΆαžŸαž‘αž’αžšαž”αžŸαžšαž”αŸαž‘αžŸαž‡αž”αž“ αž“αž„

αž…αž”αžΆαž”αžšαž€αžŸαžΆαžŸαž‘αž’αžšαž”αžŸαžšαž”αŸαž‘αžŸαŸαž•αžŸαž„αŸ—αž˜αž“αžšαžαžœαž”αžΆαž“αž’αž“αžœαžαžαŸαž‘αž™ αŸαž”αžŸαž“αž‡αžΆαž‚αžΆαž˜ αž“αž€αžΆαžšαž™αž›αžšαž–αž˜αž–αžšαž€αž˜αž αž“αŸαž™αž„αžαžαžΆαž˜

αžšαž™αŸˆαž›αžΆαž™αž›αž€αžαžŽαž’αž€αžŸαžšαž‡αžΆαž˜αž“αŸαž“αžΆαŸ‡αŸαž‘ αž‚αž˜αž“αž’αž“αž‰αžΆαž‰ αžαŸαž’αžΆαž™ αž’αž“αž€αž“αž–αž“αž’ αž™αž€αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αž”αžΆαž“αŸ‚αž€αžŸαžšαž˜αž›αžšαž…αŸαž“αŸ…

αžšαž€αž˜αž αž“αŸαž™αž„αžαž™αž€αŸαž‘αŸ…αŸαž”αžΆαŸ‡αž–αž˜αž–αŸαž“αŸ…αž‘αžŸαžŸαž“αžΆαžœαžŠαžαžŠαŸƒαž‘αŸαž“αžΆαŸ‡αŸαž‘ αŸ”

5. αž’αž“αž€αž“αž–αž“αž’ αž˜αž“αž’αžΆαž…αž‡αž‘αžΆαžŸαŸαž‘αŸ…αž“αž„αž€αžΆαžšαž”αž€αŸ‚αžšαž” αž¬αž€αžΆαžšαŸ‚αž€αžŸαžšαž˜αž›αŸƒαž“αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αžšαž€αž˜αž αž“αŸαž™αž„αž”αžΆαž“αŸαž’αžœαŸαž‘αž™ αŸ”

6. αž’αž“αž€αž“αž–αž“αž’αžšαžαžœαž’αžΆαž“αžΆαžαžΆ αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αž”αžΆαž“αžŸαžšαŸαžŸαžš αž˜αž“αžŸαžαžαŸαž“αŸ…αŸαžšαž€αžΆαž˜αž€αžΆαžšαžšαž€αžŸαžΆαžšαžŸαž‘αž’αžšαž”αžŸαž’αž“αž€αžŠαŸƒαž‘

αž€αžŠαž…αž‡αžΆαž”αŸ‡αž–αžΆαž›αžŠαž›αž€αžαžαž™αžŸ αžŸαž‘αž’αž•αžΆαž‘ αž›αžαž›αž“ αž―αž€αž‡αž“αž—αžΆαž– αž“αž„αžŸαž‘αž’αŸαž•αžŸαž„αŸαž‘αŸ€αžαžšαž”αžŸαž’αž“αž€αžŠαŸƒαž‘αŸαž‘αž™ αŸ” αžšαž€αž˜αž’αž“αž€

αžšαžŸαžΆαžœαžšαž‡αžΆαžœαŸ‚αž•αž“αž€αŸαžœαž‡αž‡αžŸαžΆαžšαžŸαžαžšαžαžœαŸ‚αžαŸαž’αžœαžαžΆαž˜αŸαžŸαž…αž€αžαžšαž”αž€αžΆαžŸαžšαž”αžŸαž‘αžšαž€αž„ Helsinki αž“αž„ αž–αž…αžΆαžšαžŽαžΆαžœαž‡αžΆαž‡ αž‡αžœαŸˆαžšαž”αž€αž”αŸαžŠαžΆαž™

αžšαž€αž˜αžŸαž›αž’αž˜ αŸ”

αž€αžΆαžšαž–αŸαžŸαžΆαž’αž“αŸαž‘αŸ…αŸαž›αžŸαžαžœαžšαžαžœαŸαž’αžœαŸαž‘αž„αŸαž“αŸ…αž€αž“αž„αŸ‚αž”αž”αž”αž‘αž˜αž™αŸ‚αžŠαž›αž•αžαž›αž€αžΆαžšαž™αž€αž…αžαžŠαž‘αž€αžŠαžΆαž€αŸαž‘αŸ…αŸαž›αž€αžΆαžšαž€αžΆαžšαž–αžΆαžšαžŸαžαžœ αŸ”

αž€αž“αž„αž€αžšαžŽαž’αžαžαž”αž‘αŸ‚αžŠαž›αž”αžΆαž“αžŸαžšαŸαžŸαžšαž˜αžΆαž“αž‡αžΆαž”αž–αžΆαž€αž–αž“αž’αž“αž„αž’αžαžαžšαž”αŸαž™αžΆαž‡αž“αžšαž”αžŸαž”αž‚αž‚αž› ឬ αž’αž„αž‚αž€αžΆαžš ឬ

αžšαž€αž˜αž αž“αŸαž“αžΆαŸ‡ αž’αž“αž€αž“αž–αž“αž’αžšαžαžœαžŸαžšαŸαžŸαžšαž”αž‰αžΆαž‡ αž€αž’αž–αž’αžαžαžšαž”αŸαž™αžΆαž‡αž“ ឬ αž•αž›αž”αŸ‡αž–αžΆαž›αŸ‚αžŠαž›αž’αžΆαž…αŸαž€αžαž˜αžΆαž“αž‘αžΆαž„αŸαž“αžΆαŸ‡

αŸαž‘αŸ…αž€αž“αž„αž’αžαžαž”αž‘αŸ‚αžŠαž›αž”αžΆαž“αžŸαžšαŸαžŸαžšαž•αž„αŸ‚αžŠαžšαŸ”

7. αž’αž“αž€αž“αž–αž“αž’ αž’αžΆαž…αž™αž€αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αž”αžΆαž“αžšαž”αž€αžΆαžŸαžšαž…αž“αžΆαž―αžŸαž€αžΆαž αžŸαž›αžΆαž¬αž‘αžŸαžŸαž“αžΆαžœαžŠαžαŸαž•αžŸαž„αŸ—αž˜αž€αžŠαžΆαž€αž”αžΆαž“ αŸ” αž€αž”αŸ‚αž“αž

αž€αž“αž„αž€αžšαžŽαž…αž“αž…αž˜αž™αž…αž“αž“αŸ‚αžŠαž›αž”αžΆαž“αžŸαžšαŸαžŸαžšαŸαž“αŸ…αž€αž“αž„αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αž”αžΆαž“αžŠαžΆαž€αž‡αž“

αž˜αžΆαž“αž’αžαžαž“αž™αžŠαž…αž‚αžΆαž“ αžαžΆαž› αž„αŸαž‘αŸ…αž“αž„αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αž”αžΆαž“αŸαž…αž‰αž•αžŸαžΆαž™αžšαž…αžšαžΆαž›αŸαž“αŸ…αž€αž“αž„αž‘αžŸαžŸαž“αžΆαžœαžŠαžαžŠαŸƒαž‘αŸαž“αžΆαŸ‡ αž’αž“αž€αž“αž–αž“αž’ រតវ

αž–αž“αžαž™αŸαž’αžΆαž™αž…αž”αžΆαžŸαŸαžŠαžΆαž™αž•αžΆαž‘ αž›αž‡αžΆαž˜αž™αž“αž„αž”αž‘αž”αž‰αž‰αžαžαŸƒαž“αž€αžΆαžšαž…αŸ‡αž•αžŸαžΆαž™αž€αžŠαž…αž‡αžΆαž”αž‘αž”αž‰αžΆαž‡ αŸƒαž“αž€αžΆαžšαž…αž›αžšαž˜αžŸαž€αžΆαž αžŸαž›αžΆ

αž¬αžšαžαžœαŸαž’αžœαž€αžΆαžšαž‘αž“αžΆαž€αž‘αž“αž„αž‡αžΆαž˜αž“αŸαž‘αŸ…αž€αžΆαž“αž˜αžΆαž… αžŸαŸαžŠαž˜αŸƒαž“αžŸαžΆαžšαžŽαžΆαž€αž“αž„αž€αžšαžŽαž…αžΆαž”αžΆαž…αŸαžŠαž˜αž”αŸαž’αžœαž€αžΆαžšαžŸαž’αž“αž‰αžΆαž‰ αžαžŸαžšαž˜αž„

αž’αžαžαž”αž‘ αž€αž“αž„αŸαž‚αžΆαž›αž”αžŽαž„αŸαž‡αŸ€αžŸαžœαžΆαž„αž€αžΆαžšαžšαŸαž›αžΆαž—αž”αž–αžΆαž“αŸαž›αžšαž€αž˜αžŸαž›αž’αž˜αŸƒαž“αž€αžΆαžšαžšαžŸαžΆαžœαžšαž‡αžΆαžœ αŸ” αŸαž›αžŸαž–αŸαž“αŸ‡ αž’αž“αž€αž“αž–αž“αž’

αžšαžαžœαžŸαžšαŸαžŸαžšαŸαž’αžΆαž™αž”αžΆαž“αž…αž”αžΆαžŸαž–αžšαž”αž—αž–αŸ‚αžŠαž›αž”αžΆαž“αžŠαž€αžšαžŸαž„αžŠαž…αž‡αžΆ េឈអម αŸ‡αŸαžŸαŸ€αžœαŸαž—αŸ… េឈអម αŸ‡αž’αž“αž€αž“αž–αž“αž’

αŸƒαžαž„αŸαž…αž‰αž•αžŸαžΆαž™ αž“αž„ αž‘αž–αžšαž‡αžΆαŸαžŠαž˜αž•αž„αŸ‚αžŠαžš αŸ”

8. αž‘αžŸαžŸαž“αžΆαžœαžŠαžαžšαž”αžŸαŸαž™αž„αž αž˜αž“αŸαž’αžœαž€αžΆαžšαž αžΆαž˜αžšαž”αžΆαž˜ αž’αž“αž€αž“αž–αž“αž’ αž–αž€αžΆαžšαž™αž€αžŸαžΆαžšαžŽαžΆαŸαž‘αŸ…αŸαž…αž‰αž•αžŸαžΆαž™αŸαž“αŸ…αž‘αžŸαžŸαž“αžΆαžœαžŠαžαžŠαŸƒαž‘

αŸαž‘αž™ αŸ” αž€αž”αŸ‚αž“αž αŸαž™αž„αžαžŸαž˜αž‡αžšαž˜αžΆαž”αž•αž„αŸ‚αžŠαžšαžαžΆ αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αžŠαžΆαž€αž‡αž“αž‘αžŸαžŸαž“αžΆαžœαžŠαžαŸαž™αž„αžαŸαž αž™

αž’αžΆαž…αž“αž„αž˜αž“αž’αžΆαž…αž…αŸ‡αž•αžŸαžΆαž™αž˜αžαž„αŸαž‘αŸ€αžαŸαž“αŸ…αžšαž€αž˜αž αž“αž‘αžŸαžŸαž“αžΆαžœαžŠαžαŸαž“αžΆαŸ‡αŸαž‘ αŸ” αž˜αž™αžΆαž„αžœαž‰αŸαž‘αŸ€αž

αŸαž™αž„αž€αžŸαž˜αž”αž‰αžΆαž‡ αž€αž•αž„αŸ‚αžŠαžšαžαžΆ αž€αž“αž„αž€αžšαžŽαž’αž“αž€αž“αž–αž“αž’αž™αž€αžŸαžΆαžšαžŽαžΆαž˜αž€αžŠαžΆαž€αž‡αž“αŸαž™αž„αž αŸαž’αžœαŸαž’αžΆαž™αžŸαžΆαžšαžŽαžΆαžŠαŸ‚αžŠαž›

αŸαž“αžΆαŸ‡αž˜αž“αž’αžΆαž…αž™αž€αŸαž‘αŸ…αž•αžŸαžΆαž™αž€αž“αž„αž‘αžŸαžŸαž“αžΆαžœαžŠαžαžŠαŸƒαž‘ αŸαž™αž„αžαž˜αž“αž‘αž‘αž›αžαžŸαžšαžαžœαŸαž‘αž™ αŸ”

9. αž€αžΆαžšαŸαžšαž‡αžŸαŸαžšαžŸαžŸαžΆαžšαžŽαžΆ αŸαž’αžœαŸαž‘αž„αŸαžŠαžΆαž™αž€αžΆαžšαžœαžΆαž™αžαŸƒαž˜αž›αž–αž‚αžŽαŸˆαž€αž˜αžΆαž˜ αž’αž€αžΆαžšαŸαžšαŸ€αž”αž…αž€αžΆαžšαŸαž”αžΆαŸ‡αž–αž˜αž–αž•αžŸαžΆαž™

αŸαžŠαžΆαž™αž˜αžΆαž“αž€αžΆαžšαž–αž“αžαž™αŸαž‘αž„αžœαž‰αž‡αžΆαž˜αž“ αŸ”

10. αžŸαžΆαžšαžŽαžΆαŸ‚αžŠαž›αž”αžΆαž“αžŠαžΆαž€αž‡αž“αŸαž αž™αž˜αž“αž’αžΆαž…αžŠαž€αžœαž‰αž”αžΆαž“αŸαž“αžΆαŸ‡αŸαž‘ αŸ”

11. αž€αžΆαžšαŸ‚αž€αžαžšαž˜αžœαžšαž”αžŸαž’αž“αž€αž“αž–αž“αž’αž’αžΆαž…αŸαž’αžœαŸαž‘αž„αž”αžΆαž“αŸ‚αžαž˜αžαž„αž”αŸαžŽαžΆαžŽ αŸ‡αžαžΆαž˜αž€αžΆαž›αž”αžšαŸαž…αž†αž‘αž€αžŽαžαŸ‚αžŠαž›αž”αžΆαž“αŸαžŸαž“αŸ” αž’αž“αž€αž“αž–αž“αž’

αž’αžΆαž…αŸ‚αž€αžαžšαž˜αžœαž”αžΆαž“αž€αž“αž„αž€αžšαžŽαž”αžΆαžαž–αžΆαž€αž™ ឬ αžαžŸαž’αž€αžΆαž αžœαžšαž‘αž’αž”αŸαžŽαžΆαžŽ αŸ‡ αŸ” αž˜αž“αžšαžαžœαžŸαžšαŸαžŸαžšαž”αŸ‚αž“αžαž˜αŸαž“αžΆαŸ‡αŸαž‘ αŸ”

12. 1) αžŸαžΆαžšαžŽαžΆαžšαžαžœαžŸαžšαŸαžŸαžšαŸαžŠαžΆαž™αŸαžšαž”αž€αž–αž™αž‘αžš αŸ”

2) αžšαžαžœαŸαžšαž”αžαžΆαž“ ត A4 αž”αž‰αžˆαžš αž“αž„ αž˜αžΆαž“αž‚αž›αžΆαžαžŸαž˜αžšαžŸαž” αŸ”

13. αž‘αžΆαž„αž’αž“αž€αž“αž–αž“αž’ αž“αž„ αžšαž€αž˜αž αž“αž“αž„αž˜αž“αžšαžαžœαž”αžΆαž“αž”αž„αžšαž”αžΆαž€αžŸαžšαž˜αžΆαž”αž€αžΆαžšαŸαž”αžΆαŸ‡αž–αž˜αž—αž•αžŸαžΆαž™αŸαž“αŸ…αž€αž“αž„αž‘αžŸαžŸαž“αžΆαžœαžŠαžαŸαž“αžΆαŸ‡αŸαž‘ αŸ”

14. αžŸαž˜αž™αž€αžŸαžΆαžšαžŽαžΆαžšαž”αžŸαž’αž“αž€αž˜αž€αžŠαžΆαž€αž‡αž“αžαžΆαž˜αžšαž™αŸˆαž’αžΆαžŸαž™αžŠαžΆαž‹ αž“αžαžΆαž„αŸαžšαž€αžΆαž˜ :

Reiseikai Media (Cambodia) Co.,Ltd.18/F Canadia Tower, No.315, Ang Doung St,

Corner Monivong Blvd, Phnom Penh,Cambodia

E-mail: [email protected]

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 2016

Β©2016 The AuthersCambodian Journal of Nephrology Vol.1, No.1, November 201616 17

Provisional Editors : Hideki Kawanishi Japan Kazunari Yoshida JapanAkihiro Yamashita Japan Toru Hyodo JapanNobuhisa Shibahara Japan Sovandy Chan CambodiaFumitaka Nakajima Japan Kenichi Kokubo JapanToshihide Naganuma Japan Tomotaka Naramura JapanSamnang Chin Cambodia

The Cambodian Journal of Nephrology

Intercultural β€œmedia” for all people concerned in healthcare and for all children

18/F Canadia Tower, No.315, Ang Doung St, Corner Monivong Blvd, Phnom Penh, Cambodiahttp://www.reiseikai-media.org/index-e.html

Publication of books and magazines

Planning, creation, and renewal of websites.

Translation services between Khmer, English, and Japanese languages.

Support in planning and organizing various academic meetings and training events.

Import, export and sale of healthcare items.

Publisher : The Cambodian Journal of Nephrology is published by Reiseikai Media (Cambodia) Co.,Ltd. <Representative director, CEO> Haruki Wakai <Office address> 18/F Canadia Tower, No.315, Ang Doung St, Corner Monivong Blvd, Phnom Penh, Cambodia <Tel> 023-962-486 (+855-23-962-486) <Fax> 023-962-310 (+855-23-962-310) <Email> [email protected] <Website> https://www.reiseikai-media.org/index-e.html https://www.reiseikai-media.org/cambodia/index-e.html β€»All rights reserved.